LifeStance Health Newsroom

Morgan Stanley Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsDec 20 13:31 ET

Buy Rating for Lifestance Health Group Amid Potential Revenue Boost From Physician Fee Adjustments

TipRanksDec 20 12:30 ET

LifeStance Health Gr Analyst Ratings

BenzingaDec 16 05:54 ET

Goldman Sachs Upgrades LifeStance Health(LFST.US) to Buy Rating, Announces Target Price $10

Moomoo NewsDec 16 05:31 ET

Morgan Stanley Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsDec 12 05:34 ET

LifeStance Health Group Is Maintained at Underweight by Barclays

Dow JonesNov 11 09:36 ET

LifeStance Health Gr Analyst Ratings

BenzingaNov 11 09:25 ET

Barclays Maintains LifeStance Health(LFST.US) With Sell Rating, Maintains Target Price $7

Moomoo NewsNov 11 03:35 ET

Barclays Sticks to Their Sell Rating for Lifestance Health Group (LFST)

TipRanksNov 10 20:19 ET

Morgan Stanley Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 8 09:31 ET

Morgan Stanley Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsSep 5 07:31 ET

LifeStance Health Gr Analyst Ratings

BenzingaAug 15 09:25 ET

LifeStance Health Gr Analyst Ratings

BenzingaAug 9 08:51 ET

Barclays Sticks to Their Sell Rating for Lifestance Health Group (LFST)

TipRanksAug 9 03:55 ET

Robust Growth and Strong Financials Drive Buy Rating for Lifestance Health Group

TipRanksAug 8 09:21 ET

Morgan Stanley Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsJul 23 06:32 ET

Buy Rating Affirmed for LifeStance Health Amid Recovery Prospects and Strategic Payor Engagements

TipRanksJul 23 06:26 ET

Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Lifestance Health Group (LFST) and Agilent (A)

TipRanksJul 23 06:26 ET

Barclays Reaffirms Their Sell Rating on Lifestance Health Group (LFST)

TipRanksMay 10 05:56 ET

LifeStance Health Gr Analyst Ratings

BenzingaApr 22 13:17 ET